BioRestorative Therapies (BRTX) Short Interest Ratio & Short Volume $1.76 +0.04 (+2.33%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BioRestorative Therapies Short Interest DataBioRestorative Therapies (BRTX) has a short interest of 207,500 shares, representing 3.82% of the float (the number of shares available for trading by the public). This marks a -37.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 550,744 shares to cover all short positions.Current Short Interest207,500 sharesPrevious Short Interest329,700 sharesChange Vs. Previous Month-37.06%Dollar Volume Sold Short$369,350.00Short Interest Ratio0.6 Days to CoverLast Record DateApril 15, 2025Outstanding Shares7,505,000 sharesFloat Size5,430,000 sharesShort Percent of Float3.82%Today's Trading Volume32,691 sharesAverage Trading Volume550,744 sharesToday's Volume Vs. Average6% Short Selling BioRestorative Therapies? Sign up to receive the latest short interest report for BioRestorative Therapies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBRTX Short Interest Over TimeBRTX Days to Cover Over TimeBRTX Percentage of Float Shorted Over Time BioRestorative Therapies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025207,500 shares $369,350.00 -37.1%3.8%0.6 $1.78 3/31/2025329,700 shares $586,866.00 -18.6%6.1%0.9 $1.78 3/15/2025405,200 shares $717,204.00 -43.4%8.1%1.1 $1.77 2/28/2025715,900 shares $1.09 million +205.8%14.3%1.8 $1.52 2/15/2025234,100 shares $536,089.00 -0.6%4.7%0.7 $2.29 1/31/2025235,600 shares $560,728.00 +81.0%4.6%3.3 $2.38 1/15/2025130,200 shares $234,360.00 +19.5%2.6%2 $1.80 12/31/2024109,000 shares $155,870.00 -28.9%2.2%2.1 $1.43 12/15/2024153,400 shares $222,430.00 +129.3%3.0%3.2 $1.45 11/30/202466,900 shares $102,357.00 -10.1%1.3%1.3 $1.53 Get the Latest News and Ratings for BRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioRestorative Therapies and its competitors with MarketBeat's FREE daily newsletter. 11/15/202474,400 shares $109,368.00 +68.3%1.5%2.9 $1.47 10/31/202444,200 shares $68,952.00 -4.3%0.9%1.7 $1.56 10/15/202446,200 shares $79,926.00 -8.2%0.9%1.9 $1.73 9/30/202450,300 shares $87,522.00 -13.9%1.0%1.7 $1.74 9/15/202458,400 shares $98,696.00 +13.4%1.2%1 $1.69 8/31/202451,500 shares $84,460.00 -15.3%1.0%0 $1.64 8/15/202460,800 shares $100,320.00 -17.4%1.2%0 $1.65 7/31/202473,600 shares $112,608.00 -48.9%1.3%0 $1.53 7/15/2024144,000 shares $254,880.00 -46.4%2.6%0.1 $1.77 6/30/2024268,800 shares $545,664.00 -85.6%4.9%0.1 $2.03 6/15/20241,870,000 shares $3.46 million +2,211.5%34.0%0.9 $1.85 5/31/202480,900 shares $101,125.00 -39.0%1.5%0.2 $1.25 5/15/2024132,600 shares $181,662.00 -21.8%2.4%0.2 $1.37 4/30/2024169,600 shares $240,832.00 +322.9%3.5%0.3 $1.42 4/15/202440,100 shares $52,130.00 -1.0%0.8%0.1 $1.30 3/31/202440,500 shares $55,890.00 +103.5%0.8%0.1 $1.38 3/15/202419,900 shares $26,467.00 +197.0%0.6%0 $1.33 2/29/20246,700 shares $9,380.00 -90.9%0.2%0 $1.40 2/15/202473,500 shares $108,045.00 +260.3%2.1%0.2 $1.47 1/31/202420,400 shares $33,252.00 +121.7%0.6%0.1 $1.63 1/15/20249,200 shares $14,720.00 -48.9%0.3%0.6 $1.60 12/31/202318,000 shares $31,318.20 -52.1%0.5%1.1 $1.74 12/15/202337,600 shares $71,440.00 +64.2%1.0%1.9 $1.90 11/30/202322,900 shares $43,968.00 -26.1%0.6%0.7 $1.92 11/15/202331,000 shares $56,575.00 -33.6%0.8%0.9 $1.83 10/31/202346,700 shares $92,466.00 -30.3%1.3%1.3 $1.98 10/15/202367,000 shares $148,070.00 -5.1%1.8%1.6 $2.21 9/30/202370,600 shares $126,374.00 +256.6%1.9%1.1 $1.79 9/15/202319,800 shares $33,066.00 -19.8%0.5%0.2 $1.67 8/31/202324,700 shares $54,340.00 -30.0%0.7%0.3 $2.20Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad)Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so. Musk has been quietly creating one of the most ambitious AI ventures in history.For all the details - including the name and ticker of our #1 AI stock to buy right now - click here 8/15/202335,300 shares $0.00 -47.3%1.0%0.5 $0.00 BRTX Short Interest - Frequently Asked Questions What is BioRestorative Therapies' current short interest? Short interest is the volume of BioRestorative Therapies shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 207,500 shares of BRTX short. 3.82% of BioRestorative Therapies' shares are currently sold short. Learn More on BioRestorative Therapies' current short interest. What is a good short interest ratio for BioRestorative Therapies? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BRTX shares currently have a short interest ratio of 1.0. Learn More on BioRestorative Therapies's short interest ratio. What is a good short interest percentage for BioRestorative Therapies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.82% of BioRestorative Therapies' floating shares are currently sold short. Is BioRestorative Therapies' short interest increasing or decreasing? BioRestorative Therapies saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 207,500 shares, a decrease of 37.1% from the previous total of 329,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BioRestorative Therapies' float size? BioRestorative Therapies currently has issued a total of 7,505,000 shares. Some of BioRestorative Therapies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioRestorative Therapies currently has a public float of 5,430,000 shares. How does BioRestorative Therapies' short interest compare to its competitors? 3.82% of BioRestorative Therapies' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to BioRestorative Therapies: Burning Rock Biotech Limited (0.48%), Concord Medical Services Holdings Limited (0.78%), Enzo Biochem, Inc. (0.97%), Mangoceuticals, Inc. (5.71%), Kindly MD, Inc. (4.18%), Ontrak, Inc. (0.89%), BioNexus Gene Lab Corp. (26.50%), Aclarion, Inc. (6.28%), Vsee Health, Inc. (0.63%), ATI Physical Therapy, Inc. (5.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short BioRestorative Therapies stock? Short selling BRTX is an investing strategy that aims to generate trading profit from BioRestorative Therapies as its price is falling. BRTX shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioRestorative Therapies? A short squeeze for BioRestorative Therapies occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BRTX, which in turn drives the price of the stock up even further. How often is BioRestorative Therapies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BRTX, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Burning Rock Biotech Short Interest Data Concord Medical Services Short Interest Data Enzo Biochem Short Interest Data Mangoceuticals Short Interest Data Kindly MD Short Interest Data Ontrak Short Interest Data BioNexus Gene Lab Short Interest Data Aclarion Short Interest Data Vsee Health Short Interest Data ATI Physical Therapy Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BRTX) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioRestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioRestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.